Literature DB >> 30933712

A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion.

Noriyuki Miyaue1, Yuki Yamanishi2, Satoshi Tada2, Rina Ando2, Hayato Yabe3, Masahiro Nagai2, Masahiro Nomoto2.   

Abstract

A 20-year-old woman suffered right facial paralysis. The patient showed an abnormality in the perception of speech at an age of 25 years. At an age of 32 years, she developed acute headache and fever. Brain magnetic resonance imaging (MRI) showed an expanded high signal intensity lesion with gadolinium enhancement in the white matter of the left frontal lobe, which was suggestive of tumefactive demyelinating lesion (TDL). A brain tumor was suspected because TDL is a large demyelinating brain lesion mimicking a primary brain tumor. After initiation of steroid therapy, the symptoms and MRI abnormalities improved. At an age of 34 years, she was referred to our hospital with the main complaint of weakness of lips on the left side. Brain MRI showed hyperintense lesions involving the left frontal and the right parietal white matter lobes, and the left ventrolateral pons, which was suggestive of acute disseminated encephalomyelitis (ADEM). Analysis of anti-MOG antibodies identified anti-MOG antibodies both in the serum and in the CSF. Steroid therapy led to complete clinical recovery. MOG antibodies in both serum and CSF were negative six months after the previous measurement. The patient fulfilled the diagnostic criteria for multiple sclerosis (MS) and TDL is one of the rare variants of MS. This study suggests that anti-MOG antibodies can be associated with repetitive encephalitis including TDL and ADEM-like presentation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ADEM; Facial paralysis; MOG antibody; MS; Tumefactive demyelinating lesion

Mesh:

Substances:

Year:  2019        PMID: 30933712     DOI: 10.1016/j.msard.2019.03.018

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  4 in total

1.  Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature.

Authors:  Aigli G Vakrakou; Dimitrios Tzanetakos; Theodore Argyrakos; Georgios Koutsis; Maria-Eleptheria Evangelopoulos; Elisabeth Andreadou; Maria Anagnostouli; Marianthi Breza; John S Tzartos; Elias Gialafos; Antonios N Dimitrakopoulos; Georgios Velonakis; Panagiotis Toulas; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2020-06-30       Impact factor: 4.003

Review 2.  Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases.

Authors:  Aigli G Vakrakou; Maria-Evgenia Brinia; Ioanna Svolaki; Theodore Argyrakos; Leonidas Stefanis; Constantinos Kilidireas
Journal:  Front Neurol       Date:  2022-03-15       Impact factor: 4.003

3.  Tumefactive Demyelination-A Rare Presentation of Anti-MOG Syndrome.

Authors:  Sesh Sivadasan; Rajalakshmi Poyuran
Journal:  Ann Indian Acad Neurol       Date:  2021-04-21       Impact factor: 1.383

4.  Clinical and Imaging Features of Patients With Encephalitic Symptoms and Myelin Oligodendrocyte Glycoprotein Antibodies.

Authors:  Jingsi Wang; Zhandong Qiu; Dawei Li; Xixi Yang; Yan Ding; Lehong Gao; Aihua Liu; Yang Song; Cunjiang Li; Ran Gao; Lin Wang; Liyong Wu; Longfei Jia; Dongmei Guo; Aihong Zhou; Jianping Jia; Liyuan Huang; Miao Qu; Li Gao; Huiqing Dong; Junwei Hao; Zheng Liu
Journal:  Front Immunol       Date:  2021-10-07       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.